Aloe-emodin exerts cholesterol-lowering effects by inhibiting proprotein convertase subtilisin/kexin type 9 in hyperlipidemic rats. [electronic resource]
- Acta pharmacologica Sinica Aug 2020
- 1085-1092 p. digital
Publication Type: Journal Article
1745-7254
10.1038/s41401-020-0392-8 doi
Animals Anthraquinones--therapeutic use Anticholesteremic Agents--therapeutic use Diet, High-Fat Hep G2 Cells Humans Hyperlipidemias--drug therapy Intracellular Signaling Peptides and Proteins--metabolism Male Membrane Proteins--metabolism PCSK9 Inhibitors Rats, Wistar Receptors, LDL--metabolism Signal Transduction--drug effects Sterol Regulatory Element Binding Proteins--metabolism